Showing results (61-70 of 210) with videos related to
Sort By:
Pageof 21
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion StudyMaria-Victoria Mateos, Katja Weisel, Joris Diels, et al.Leukemia & Lymphoma|November 9, 2018
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysisKatja Weisel, Pieter Sonneveld, Andrew Spencer, et al.Frontiers in Oncology|January 21, 2025
Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unitPanagiotis Karagiannis, Felix Klingler, Viktor Arelin, et al.Clinical Lymphoma, Myeloma & Leukemia|March 14, 2025
Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR TrialKatja Weisel, Maria-Victoria Mateos, Ola Landgren, et al.Clinical Lymphoma, Myeloma & Leukemia|July 15, 2026
Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center CohortRicardo Kosch, Winfried Alsdorf, Paymon Ahmadi, et al.Frontiers in Medicine|November 25, 2021
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and MyelomaFranziska Brauneck, Pauline Weimer, Julian Schulze Zur Wiesch, et al.Annals of Hematology|January 8, 2025
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodiesLuciano J Costa, Francesca Gay, Ola Landgren, et al.Leukemia & Lymphoma|April 26, 2021
Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myelomaPaula Rodriguez-Otero, Dieter Ayers, Shannon Cope, et al.European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 22, 2026
Dorsal spinal instrumentation in multiple myeloma: postoperative acute kidney injury is associated with mortality, morbidity, and deterioration of bone and muscle statusJulian Kylies, Leon-Gordian Leonhardt, Elias Brauneck, et al.Oncotargets and Therapy|September 3, 2025
The Role of CELMoD Agents in Multiple MyelomaNiels W C J van de Donk, Nizar J Bahlis, Charlotte Pawlyn, et al.Pageof 21